COVERAGE HUB
$PPBT
2 articles in last 30 days
LAST 30 DAYS
2 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BEARISH
TOTAL VIEWS
0
1-DAY GRADE TIMELINE
2026-06-11
TODAY
RECENT COVERAGE · 2 ARTICLES
Purple Biotech Stock Falls 35% After Announcement Of Preclinical Data From IM1240 Study
PPBT experienced a severe sell-off of approximately 35% following disclosure of preclinical findings from its IM1240 study, a component...
Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window
Purple Biotech (PPBT) unveiled preclinical efficacy and safety data for its lead candidate IM1240 at EACR 2026, demonstrating improved...